Bioforce Nanosciences Holdings Stock Fundamentals
| BFNH Stock | USD 1.09 0.00 0.00% |
BioForce Nanosciences Holdings fundamentals help investors to digest information that contributes to BioForce Nanosciences' financial success or failures. It also enables traders to predict the movement of BioForce Pink Sheet. The fundamental analysis module provides a way to measure BioForce Nanosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BioForce Nanosciences pink sheet.
BioForce |
BioForce Nanosciences Holdings Company Shares Owned By Insiders Analysis
BioForce Nanosciences' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current BioForce Nanosciences Shares Owned By Insiders | 82.29 % |
Most of BioForce Nanosciences' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BioForce Nanosciences Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
| Competition |
Based on the latest financial disclosure, 82% of BioForce Nanosciences Holdings are shares owned by insiders. This is much higher than that of the Consumer Defensive sector and 216.01% higher than that of the Packaged Foods industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
BioForce Nanosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioForce Nanosciences's current stock value. Our valuation model uses many indicators to compare BioForce Nanosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioForce Nanosciences competition to find correlations between indicators driving BioForce Nanosciences's intrinsic value. More Info.BioForce Nanosciences Holdings is rated below average in return on asset category among its peers. It also is rated below average in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value BioForce Nanosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioForce Nanosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioForce Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BioForce Nanosciences' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BioForce Nanosciences could also be used in its relative valuation, which is a method of valuing BioForce Nanosciences by comparing valuation metrics of similar companies.BioForce Nanosciences is currently under evaluation in shares owned by insiders category among its peers.
BioForce Fundamentals
| Return On Asset | -21.84 | |||
| Current Valuation | 50.2 M | |||
| Shares Outstanding | 29.27 M | |||
| Shares Owned By Insiders | 82.29 % | |||
| Price To Earning | (1.52) X | |||
| Price To Book | 866.24 X | |||
| Price To Sales | 3,841 X | |||
| Gross Profit | 4.36 K | |||
| EBITDA | (501.95 K) | |||
| Net Income | (501.95 K) | |||
| Cash And Equivalents | 9.23 K | |||
| Total Debt | 156.87 K | |||
| Debt To Equity | 4.61 % | |||
| Current Ratio | 0.01 X | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (77.77 K) | |||
| Earnings Per Share | (0.02) X | |||
| Target Price | 0.25 | |||
| Beta | -1.93 | |||
| Market Capitalization | 72.74 M | |||
| Total Asset | 11.14 K | |||
| Retained Earnings | (21 K) | |||
| Working Capital | 14 K | |||
| Current Asset | 15 K | |||
| Current Liabilities | 1 K | |||
| Net Asset | 11.14 K |
About BioForce Nanosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze BioForce Nanosciences Holdings's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioForce Nanosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioForce Nanosciences Holdings based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. BIOFORCE NANOSCIENCES operates under Packaged Foods classification in the United States and is traded on OTC Exchange. It employs 2 people.
Currently Active Assets on Macroaxis
Other Information on Investing in BioForce Pink Sheet
BioForce Nanosciences financial ratios help investors to determine whether BioForce Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioForce with respect to the benefits of owning BioForce Nanosciences security.